ARCHIVES

Studies Question PSA Screening: PLCO Trial Finds No Survival Advantage, European Trial Finds Benefit At High Cost

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | March 20, 2009

Download PDF Visit The Full Archive

Related Articles

Group Chairmen Object To “Directive” Language In Proposed Intergroup Study Guidelines

January 13, 1984

Roswell Park Celebrates 50th Anniversary of Pivotal Congressional Visit

October 20, 2021

FDA Policy: silicone Breast Implant Restrictions Stand, FDA Tells Petitioners

November 7, 1997

Nixon to Receive ACCC Annual Award

January 10, 1986

CVS To Stop Tobacco Sales at Pharmacies

February 7, 2014

NIH, NCI Being Discussions With HCFA On Reimbursement

April 26, 1996